Episode 162: Overtime: Peptides, PR, and Patient Demand: Separating Science from Social Media

Welcome to Overtime with the Sports Docs. On each of these mini episodes, Catherine and I chat about a new technique or treatment option in the field of sports medicine. We’ll give you our quick take on the most recent data and how this data will impact our practice.

Today we’re tackling a topic that’s coming up more and more in clinic, locker rooms, and social media—injectable peptide therapy. Specifically, we’re going to walk through a recent AJSM narrative review by Mayfield and colleagues that serves as a primer for orthopaedic and sports medicine physicians.

This is a great paper because it separates biologic plausibility from clinical reality. Patients are asking about BPC-157, TB-500, growth hormone–releasing peptides — often convinced these are regenerative breakthroughs — while the evidence base is still extremely limited. So, let's get started!

Links:

https://pubmed.ncbi.nlm.nih.gov/41476424/

www.cloganmd.com 

https://orthopedicnj.com/physicians/ashley-bassett